The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Open accessAbstract
Purpose: Recent advances in imaging, use of prognostic indices, and molecular profiling techniques have the potential to improve disease characterization and outcomes in lymphoma. International trials are under way to test image-based response–adapted treatment guided by early interim positron emission tomography (PET) –computed tomography (CT). Progress in imaging is influencing trial design and affecting clinical practice. In particular, a five-point scale to grade response using PET-CT, which can be adapted to suit requirements for early- and late-response assessment with good interobserver agreement, is becoming widely used both in practice- and response-adapted trials. A workshop held at the 11th International Conference on Malignant Lymphomas (ICML) in 2011 concluded that revision to current staging and response criteria was timely. Methods: An imaging working group composed of representatives from major international cooperative groups was asked to review the literature, share knowledge about research in progress, and identify key areas for research pertaining to imaging and lymphoma. Results: A working paper was circulated for comment and presented at the Fourth International Workshop on PET in Lymphoma in Menton, France, and the 12th ICML in Lugano, Switzerland, to update the International Harmonisation Project guidance regarding PET. Recommendations were made to optimize the use of PET-CT in staging and response assessment of lymphoma, including qualitative and quantitative methods. Conclusion: This article comprises the consensus reached to update guidance on the use of PET-CT for staging and response assessment for [18 F]fluorodeoxyglucose-avid lymphomas in clinical practice and late-phase trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Self-citationRosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationFrom RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Self-citationYoung, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
Self-citationLister, T. A., Crowther, D., Sutcliffe, S. B., Glatstein, E., Canellos, G. P., Young, R. C., Rosenberg, S. A., Coltman, C. A., & Tubiana, M. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1630 · Cited by 1,639
Follicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Self-citationFDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326
Self-citationSehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K., Klasa, R., MacPherson, N., O'Reilly, S., Spinelli, J. J., Sutherland, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.137 · Cited by 987
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Hoster, E., Dreyling, M., Klapper, W., Gisselbrecht, C., van Hoof, A., Kluin-Nelemans, H. C., Pfreundschuh, M., Reiser, M., Metzner, B., Einsele, H., et al. (2008) · Blood · doi:10.1182/blood-2007-06-095331 · Cited by 984
Standards for PET Image Acquisition and Quantitative Data Analysis
Boellaard, R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057182 · Cited by 902
Gallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Self-citationPfreundschuh, M., Kuhnt, E., Trümper, L., Österborg, A., Trneny, M., Shepherd, L., Gill, D. S., Walewski, J., Pettengell, R., Jaeger, U., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70235-2 · Cited by 792
Report on the First International Workshop on interim-PET scan in lymphoma
Meignan, M., Gallamini, A., Meignan, M., Gallamini, A., & Haioun, C. (2009) · Leukemia & Lymphoma · doi:10.1080/10428190903040048 · Cited by 754
Self-citationFederico, M., Bellei, M., Marcheselli, L., Luminari, S., Lopez-Guillermo, A., Vitolo, U., Pro, B., Pileri, S., Pulsoni, A., Soubeyran, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3991 · Cited by 751
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
Self-citationShankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 674
Engert, A., Haverkamp, H., Kobe, C., Markova, J., Renner, C., Ho, A., Zijlstra, J., Král, Z., Fuchs, M., Hallek, M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61940-5 · Cited by 635
Follicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
Dunleavy, K., Pittaluga, S., Maeda, L. S., Advani, R., Chen, C. C., Hessler, J., Steinberg, S. M., Grant, C., Wright, G., Varma, G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214561 · Cited by 569
Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J.-D., Belhadj, K., Gaulard, P., Garderet, L., Lepage, E., Reyes, F., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0272 · Cited by 494
Self-citationSchöder, H., Noy, A., Gönen, M., Weng, L., Green, D., Erdi, Y. E., Larson, S. M., & Yeung, H. W. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.072 · Cited by 491
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Eichenauer, D. A., Engert, A., André, M., Federico, M., Illidge, T., Hutchings, M., & Ladetto, M. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu181 · Cited by 474
Self-citationSpaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., De Wolf-Peeters, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.414 · Cited by 465
Utility of FDG-PET scanning in lymphoma by WHO classification
Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2778 · Cited by 437
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., & Verhoef, G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf256 · Cited by 410
Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Self-citationBoellaard, R., Oyen, W. J. G., Hoekstra, C. J., Hoekstra, O. S., Visser, E. P., Willemsen, A. T., Arends, B., Verzijlbergen, F. J., Zijlstra, J., Paans, A. M., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0874-2 · Cited by 396
Self-citationLin, C., Itti, E., Haioun, C., Petegnief, Y., Luciani, A., Dupuis, J., Paone, G., Talbot, J.-N., Rahmouni, A., & Meignan, M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042093 · Cited by 394
Self-citation18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
Weiler-Sagie, M., Bushelev, O., Epelbaum, R., Dann, E. J., Haim, N., Avivi, I., Ben-Barak, A., Ben-Arie, Y., Bar-Shalom, R., & Israel, O. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.067892 · Cited by 382
Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D. M., von Schulthess, G. K., & Goerres, G. W. (2004) · Radiology · doi:10.1148/radiol.2323030985 · Cited by 364
Barrington, S. F., Qian, W., Somer, E. J., Franceschetto, A., Bagni, B., Brun, E., Almquist, H., Loft, A., Højgaard, L., Federico, M., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1490-5 · Cited by 348
Self-citationPrognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
Hutchings, M., Mikhaeel, N. G., Fields, P. A., Nunan, T., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi200 · Cited by 327
Self-citationDetection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography
Carr, R., Barrington, S. F., Madan, B., O'Doherty, M. J., Saunders, C. A. B., van der Walt, J., & Timothy, A. R. (1998) · Blood · doi:10.1182/blood.v91.9.3340 · Cited by 324
Self-citationGallamini, A., Rigacci, L., Merli, F., Nassi, L., Bosi, A., Capodanno, I., Luminari, S., Vitolo, U., Sancetta, R., Iannitto, E., et al. (2006) · PubMed · Cited by 314
Self-citationBiggi, A., Gallamini, A., Chauvie, S., Hutchings, M., Kostakoglu, L., Gregianin, M., Meignan, M., Malkowski, B., Hofman, M. S., & Barrington, S. F. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110890 · Cited by 311
Self-citationEl-Galaly, T. C., d'Amore, F., Mylam, K. J., de Nully Brown, P., Bøgsted, M., Bukh, A., Specht, L., Loft, A., Iyer, V., Hjorthaug, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.4036 · Cited by 295
Self-citationRole of Functional Imaging in the Management of Lymphoma
Cheson, B. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5225 · Cited by 280
Self-citationPitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging
Cook, G. J. R., Wegner, E. A., & Fogelman, I. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2003.12.003 · Cited by 258
Itti, E., Meignan, M., Berriolo-Riedinger, A., Biggi, A., Cashen, A. F., Véra, P., Tilly, H., Siegel, B. A., Gallamini, A., Casasnovas, R.-O., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2435-6 · Cited by 255
Self-citationTerasawa, T., Lau, J., Bardet, S., Couturier, O., Hotta, T., Hutchings, M., Nihashi, T., & Nagai, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0861 · Cited by 254
Self-citationMikhaeel, N. G., Timothy, A. R., O’Doherty, M. J., Hain, S. F., & Maisey, M. N. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009113384 · Cited by 248
Self-citationKhan, A. B., Barrington, S. F., Mikhaeel, N. G., Hunt, A. A., Cameron, L., Morris, T., & Carr, R. (2013) · Blood · doi:10.1182/blood-2012-12-473389 · Cited by 246
Self-citationBangerter, M., Moog, F., Buchmann, I., Kotzerke, J., Griesshammer, M., Hafner, M., Elsner, K., Frickhofen, N., Reske, S. N., & Bergmann, L. (1998) · Annals of Oncology · doi:10.1023/a:1008486928190 · Cited by 244
Buchmann, I., Reinhardt, M., Elsner, K., Bunjes, D., Altehoefer, C., Finke, J., Moser, E., Glatting, G., Kotzerke, J., Guhlmann, C. A., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<889::aid-cncr1078>3.0.co;2-5 · Cited by 239
Pregno, P., Chiappella, A., Bellò, M., Botto, B., Ferrero, S., Franceschetti, S., Giunta, F., Ladetto, M., Limerutti, G., Menga, M., et al. (2012) · Blood · doi:10.1182/blood-2011-06-359943 · Cited by 236
PET/CT for Therapy Response Assessment in Lymphoma
Hutchings, M., & Barrington, S. F. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057190 · Cited by 220
Self-citationJérusalem, G., Beguin, Y. P., Fassotte, M., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001) · PubMed · Cited by 218
PET scanning and the human immunodeficiency virus-positive patient.
O'Doherty, M. J., Barrington, S. F., Campbell, M., Lowe, J., & Bradbeer, C. S. (1997) · PubMed · Cited by 213
Self-citationTrotman, J., Fournier, M., Lamy, T., Seymour, J. F., Sonet, A., Janikova, A., Shpilberg, O., Gyan, E., Tilly, H., Estell, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.0736 · Cited by 208
Self-citationKaram, M., Novak, L., Cyriac, J., Ali, A., Nazeer, T., & Nugent, F. (2006) · Cancer · doi:10.1002/cncr.21967 · Cited by 200
Tsukamoto, N., Kojima, M., Hasegawa, M., Oriuchi, N., Matsushima, T., Yokohama, A., Saitoh, T., Handa, H., Endo, K., & Murakami, H. (2007) · Cancer · doi:10.1002/cncr.22807 · Cited by 193
Dupuis, J., Berriolo-Riedinger, A., Julian, A., Brice, P., Tychyj-Pinel, C., Tilly, H., Mounier, N., Gallamini, A., Feugier, P., Soubeyran, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0934 · Cited by 191
Self-citationBerthet, L., Cochet, A., Kanoun, S., Berriolo-Riedinger, A., Humbert, O., Toubeau, M., Dygai-Cochet, I., Legouge, C., Casasnovas, O., & Brunotte, F. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114710 · Cited by 173
Naumann, R., Beuthien-Baumann, B., Reiß, A., Schulze, J., Hänel, A., Bredow, J., Kühnel, G., Kropp, J., Hänel, M., Laniado, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601561 · Cited by 171
Kostakoglu, L., Goldsmith, S. J., Leonard, J. P., Christos, P., Furman, R. R., Atasever, T., Chandramouly, A., Verma, S., Kothari, P., & Coleman, M. (2006) · Cancer · doi:10.1002/cncr.22276 · Cited by 168
Self-citationMartelli, M., Ceriani, L., Zucca, E., Zinzani, P. L., Ferreri, A. J. M., Vitolo, U., Stelitano, C., Brusamolino, E., Cabras, M. G., Rigacci, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7524 · Cited by 168
Self-citationNgeow, J. Y. Y., Quek, R. H. H., Ng, D. C. E., Hee, S. W., Tao, M., Lim, L. C., Tan, Y. H., & Lim, S. T. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp030 · Cited by 164
Safar, V., Dupuis, J., Itti, E., Jardin, F., Fruchart, C., Bardet, S., Véra, P., Copie-Bergman, C., Rahmouni, A., Tilly, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2648 · Cited by 162
Self-citationKim, T. M., Paeng, J. C., Chun, I. K., Keam, B., Jeon, Y. K., Lee, S., Kim, D., Lee, D. S., Kim, C. W., Chung, J., et al. (2013) · Cancer · doi:10.1002/cncr.27855 · Cited by 159
Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments
Boellaard, R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085662 · Cited by 159
Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
de Langen, A. J., Vincent, A., Velasquez, L. M., van Tinteren, H., Boellaard, R., Shankar, L. K., Boers, M., Smit, E. F., Stroobants, S., Weber, W. A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.095299 · Cited by 157
Self-citationCerci, J. J., Pracchia, L. F., Linardi, C. C. G., Pitella, F. A., Delbeke, D., Izaki, M., Trindade, E. M., Soares, J., Buccheri, V., & Meneghetti, J. C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.073197 · Cited by 157
Cashen, A. F., Dehdashti, F., Luo, J. R., Homb, A. C., Siegel, B. A., & Bartlett, N. L. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082586 · Cited by 153
PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients
Berthelsen, A. K., Holm, S., Loft, A., Klausen, T. L., Andersen, F., & Højgaard, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1784-1 · Cited by 151
Micallef, I. N., Maurer, M. J., Wiseman, G. A., Nikcevich, D. A., Kurtin, P. J., Cannon, M. W., Pérez, D. G., Soori, G. S., Link, B. K., Habermann, T. M., et al. (2011) · Blood · doi:10.1182/blood-2011-02-336990 · Cited by 147
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma
Dortz, L. L., de Guibert, S., Bayat, S., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1539-5 · Cited by 145
Moulin-Romsee, G., Hindié, E., Cuenca, X., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1377-5 · Cited by 143
Jabbour, E. J., Hosing, C. M., Ayers, G. D., NUÑEZ, R. F., Anderlini, P. N., Pro, B., Khouri, I. F., Younes, A., Hagemeister, F. B., Kwak, L. W., et al. (2007) · Cancer · doi:10.1002/cncr.22714 · Cited by 139
Song, M.-K., Chung, J.-S., Shin, H., Lee, S., Lee, S., Lee, H. S., Lee, G., Kim, S., Lee, S.-M., & Chung, D.-S. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1357-2 · Cited by 139
Limitations of PET for imaging lymphoma
Barrington, S. F., & O'Doherty, M. J. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1169-2 · Cited by 136
Self-citationMethodological considerations in quantification of oncological FDG PET studies
Vriens, D., Visser, E. P., de Geus‐Oei, L., & Oyen, W. J. G. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1306-7 · Cited by 134
Wirth, A., Foo, M., Seymour, J. F., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.09.051 · Cited by 132
Scheuermann, J. S., Saffer, J. R., Karp, J. S., Levering, A., & Siegel, B. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057455 · Cited by 126
Elstrom, R., Leonard, J. P., Coleman, M., & Brown, R. K. J. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn282 · Cited by 120
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
Mikhaeel, N. G., Timothy, A. R., Hain, S. F., & O'Doherty, M. J. (2000) · Annals of Oncology · doi:10.1093/annonc/11.suppl_1.s147 · Cited by 114
Self-citationColeman, R. E., Delbeke, D., Guiberteau, M. J., Conti, P. S., Royal, H. D., Weinreb, J. C., Siegel, B. A., Federle, M. P., Townsend, D. W., & Berland, L. L. (2005) · PubMed · Cited by 108
Bodet‐Milin, C., Touzeau, C., Leux, C., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1469-2 · Cited by 99
Hagberg, H., & Gisselbrecht, C. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj996 · Cited by 99
Weng, L., Noy, A., YEUNG, H. W. D., et al. (2005) · Cited by 94
Roux, P. L., Gastinne, T., Gouill, S. L., Nowak, E., Bodet‐Milin, C., Querellou, S., Mahé, B., Dubruille, V., Blin, N., Salaün, P., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1741-0 · Cited by 90
Yang, D., Min, J., Song, H., Jeong, Y. Y., Chung, W., Bae, S.-Y., Ahn, J., Kim, Y., Bom, H., Chung, I., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.027 · Cited by 88
Dupuis, J., Itti, E., Rahmouni, A., Hémery, F., Gisselbrecht, C., Lin, C. K.-J., Copie‐Bergman, C., Belhadj, K., Gnaoui, T. E., Gaillard, I., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn671 · Cited by 81
Self-citationPelosi, E., Penna, D., Douroukas, A., et al. (2011) · PubMed · Cited by 78
Cerci, J. J., Trindade, E. M., Pracchia, L. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4367 · Cited by 78
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP
Yoo, C., Lee, D. H., Kim, J. E., Jo, J., Yoon, D. H., Sohn, B. S., Kim, S., Lee, J., & Suh, C. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1135-6 · Cited by 77
Nols, N., Mounier, N., Bouazza, S., Lhommel, R., Costantini, S., Borght, T. V., Vekemans, M., Sonet, A., Bosly, A., Michaux, L., et al. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.831848 · Cited by 73
18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
Casulo, C., Schöder, H. M., Feeney, J. N., Lim, R., Maragulia, J. C., Zelenetz, A. D., & Horwitz, S. M. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.767901 · Cited by 72
Marker‐controlled watershed for lymphoma segmentation in sequential CT images
Yan, J., Zhao, B., Wang, L., Zelenetz, A. D., & Schwartz, L. H. (2006) · Medical Physics · doi:10.1118/1.2207133 · Cited by 70
Self-citationPaone, G., Itti, E., Haïoun, C., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1021-9 · Cited by 68
Barrington, S. F., Mackewn, J. E., Schleyer, P., Marsden, P. K., Mikhaeel, N. G., Qian, W., Mouncey, P., Patrick, P., Popova, B., Johnson, P., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq428 · Cited by 66
Self-citationMaltezas, D., Dimopoulos, M. A., Katodritou, I., Repousis, P., Pouli, A. G., Terpos, E., Panayiotidis, P. G., Delimpasi, S., Michalis, E., Anargyrou, K., et al. (2012) · Hematological Oncology · doi:10.1002/hon.2026 · Cited by 65
Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma
Zinzani, P. L., Gandolfi, L., Broccoli, A., Argnani, L., Fanti, S., Pellegrini, C., Stefoni, V., Derenzini, E., Quirini, F., & Baccarani, M. (2010) · Cancer · doi:10.1002/cncr.25579 · Cited by 64
Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients
Roy, F.-N., Beaulieu, S., Boucher, L., Bourdeau, I., & Cohade, C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056283 · Cited by 63
When should FDG ‐ PET be used in the modern management of lymphoma?
Barrington, S. F., & Mikhaeel, N. G. (2013) · British Journal of Haematology · doi:10.1111/bjh.12601 · Cited by 63
Self-citationRecommendations for the Use of Radiotherapy in Nodal Lymphoma
Hoskin, P., Díez, P., Williams, M. V., Lucraft, H. H., & Bayne, M. (2012) · Clinical Oncology · doi:10.1016/j.clon.2012.07.011 · Cited by 63
Reinhardt, M., Herkel, C., Altehoefer, C., Finke, J., & Moser, E. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi271 · Cited by 59
Meignan, M. A., Itti, E., Bardet, S., Lumbroso, J., Edeline, V., Olivier, P., Borght, T. V., Reman, O., Karcher, G., MUNDLER, O., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4089 · Cited by 58
Self-citationInterim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
Fuertes, S., Setoaín, X., López‐Guillermo, A., Carrasco, J. L., Rodríguez, S., Rovira, J., & Pons, F. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2320-8 · Cited by 56
Pinilla, I., León, N. G., del Val, L. D. C., Hernández‐Maraver, D., Rodríguez‐Vigil, B., Jover-Díaz, R., & Coya, J. (2011) · PubMed · Cited by 54
Lymph node segmentation from CT images using fast marching method
Yan, J., Zhuang, T.-G., Zhao, B., & Schwartz, L. H. (2003) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2003.09.003 · Cited by 54
Self-citationKostakoğlu, L., Schöder, H. M., Johnson, J. L., Hall, N. C., Schwartz, L. H., Straus, D. J., LaCasce, A. S., Jung, S., Bartlett, N. L., Canellos, G. P., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.676173 · Cited by 52
Self-citationMarková, J., Kobe, C., Skopalová, M., Klásková, K., Dědečková, K., Plütschow, A., Eich, H. T., Dietlein, M., Engert, A., & Kozák, T. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn768 · Cited by 52
Terasawa, T., Dahabreh, I. J., & Nihashi, T. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0054 · Cited by 52
Interim18F-FDG PET in Hodgkin Lymphoma: Would PET-Adapted Clinical Trials Lead to a Paradigm Shift?
Kostakoğlu, L., & Gallamini, A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120451 · Cited by 50
Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas – the PETAL trial
Dührsen, U., Hüttmann, A., Jöckel, K., & Müller, S. P. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903308031 · Cited by 46
Limitations of CT During PET/CT
Gollub, M. J., Hong, R., Sarasohn, D. M. M., & Akhurst, T. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043109 · Cited by 45
Furth, C., Amthauer, H., Hautzel, H., Steffen, I. G., Ruf, J., Schiefer, J., Schönberger, S., Henze, G., Grandt, R., Hundsdoerfer, P., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq557 · Cited by 43
Bourguet, P., Blanc-Vincent, M. P., Boneu, A., Bosquet, L., Chauffert, B., Corone, C., Courbon, F., Devillers, A., Foehrenbach, H., Lumbroso, J., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601088 · Cited by 38
Mikhaeel, N. G. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903275610 · Cited by 33
Self-citationOn the Added Value of Baseline FDG-PET in Malignant Lymphoma
van Ufford, H. M. E. Q., Hoekstra, O. S., de Haas, M., et al. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0259-3 · Cited by 32
Self-citationChalaye, J., Luciani, A., Enache, C., Beaussart, P., Lhermite, C., Evangelista, E., Sasanelli, M., Safar, V., Meignan, M. A., Haïoun, C., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.900761 · Cited by 29
Self-citationHodgkin Lymphoma: Protecting the Victims of Our Success
Cheson, B. D. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5402 · Cited by 21
Self-citation
Cited by
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Self-citationFDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
“Further, a fivepoint scale has been proposed for assessment of lymphoma therapy response [80].”
Self-citationKumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M.-V., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30206-6 · Cited by 3,061
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32407-2 · Cited by 1,176
Metadata
- Authors
- Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., Hoekstra, O. S., Hicks, R. J., O'Doherty, M. J., Hustinx, R., Biggi, A., & Cheson, B. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-09-20
- Volume
- 32
- Issue
- 27
- Pages
- 3048-3058
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2131900456
- Cited by
- 1,665
- References
- 117
- FWCI
- 98.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.